http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5081105-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35435eec2acab8221f5b1a9fba78d996
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-23
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 1990-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1992-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_239ed3ec03e202766068c91b8e59e79b
publicationDate 1992-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5081105-A
titleOfInvention Method of treating cancer using structured lipids
abstract Disclosed is a method of treating cancer using nutritional support therapy by administration of a structured lipid containing both omega 3 fatty acids and medium-chain fatty acids. The therapy may be used as total parenteral nutrition or as a nutritional supplement. The addition of tumor necrosis factor may also be beneficial.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005084129-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7196065-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5571553-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6013665-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6291496-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7919526-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7732404-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005070498-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007281993-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9415464-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005084129-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004067224-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9321939-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6160007-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5962712-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006205639-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9930740-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5700782-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5661180-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5814204-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7041840-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-739233-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6864242-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004122093-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5817695-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011150944-A1
priorityDate 1988-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4528197-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4703062-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4607052-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4906664-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6209
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410725
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10690
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127378182

Total number of triples: 59.